WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

FDA opens comment on an electronic submission template for IDE applications Vincora wins an IDE to implant artificial chordae on a beating heart OrthoPediatrics clears a retrograde femur nail in 7 to 11 mm diameters Stryker closes its ZuriMED deal and takes FiberLocker into sports medicine X9 wins a Breakthrough designation for power-assisted dialysis cannulation adsilico raises 10 million pounds to test implants on virtual patients Smith+Nephew and J&J ortho merger talks collapse over who would run it Labcorp agrees to buy Millennium Health and its drug monitoring business Coreline Soft clears aortic measurement software, its 13th US clearance FDA opens comment on an electronic submission template for IDE applications Vincora wins an IDE to implant artificial chordae on a beating heart OrthoPediatrics clears a retrograde femur nail in 7 to 11 mm diameters Stryker closes its ZuriMED deal and takes FiberLocker into sports medicine X9 wins a Breakthrough designation for power-assisted dialysis cannulation adsilico raises 10 million pounds to test implants on virtual patients Smith+Nephew and J&J ortho merger talks collapse over who would run it Labcorp agrees to buy Millennium Health and its drug monitoring business Coreline Soft clears aortic measurement software, its 13th US clearance

Acquisition

Stryker closes its ZuriMED deal and takes FiberLocker into sports medicine

MedDevice Startups Staff · 2 days ago · 2 min read · Via Stryker completion release

Stryker completed its acquisition of ZuriMED on October 26, eight weeks after signing the definitive agreement on August 31. Neither company disclosed the price. The Swiss company's FiberLocker System joins Stryker's sports medicine portfolio.

FiberLocker pairs a non-degradable polyester staple fiber implant with a surgical micro-stapling device that fixes it into soft tissue during or after a rotator cuff repair. The sutures and bone anchors still carry the mechanical load of the repair. The patch is there to add strength and support healing. FDA cleared it in 2024 on bench and animal performance data.

Human evidence is still accruing. ZuriMED opened a first-in-human safety study in Switzerland in 2025 and a US multicenter trial whose primary endpoint is healing at six months on MRI. Stryker bought a commercial product with its pivotal readout ahead of it, which is the standard trade in augmentation and leaves the acquirer holding the evidence risk.

Questions & Answers

When did Stryker complete its acquisition of ZuriMED?

Stryker announced on October 26, 2026 that it had completed the acquisition of ZuriMED. It had signed the definitive agreement on August 31, 2026.

How much did Stryker pay for ZuriMED?

Neither company disclosed the price or terms of the ZuriMED acquisition, at signing or at closing.

What is the ZuriMED FiberLocker System?

FiberLocker is a rotator cuff augmentation technology from ZuriMED combining a non-degradable polyester staple fiber implant with a micro-stapling device that fixes it into soft tissue. FDA cleared it in 2024, and it is now part of Stryker's sports medicine portfolio.

← Back to M&A